NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy
Pharmacogenomics and Personalized Medicine · 2026-03 · Volume 19 · 1-8
DOI: 10.2147/pgpm.s568037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacogenomics and Personalized Medicine, 2026-03. Verfasst von Nikhat Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: ICMR-National Institute of Research in Tribal Health, Jabalpur, Madhya Pradesh, India. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ICMR-National Institute of Research in Tribal Health, Jabalpur, Madhya Pradesh, India.
- Symbiosis International University (SIU), Pune, Maharashtra, India.
- ICMR-Regional Medical Research Centre, Port Blair, Andaman and Nicobar Islands, India.
- Symbiosis School for Liberal Arts (SSLA), Symbiosis International University (SIU), Pune, Maharashtra, India.
ORCID-Profile: Nikhat Khan
Zitieren
APA
Khan, N., Jonnalagadda, M., Kumar, R., & Das, A. (2026). NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy. Pharmacogenomics and Personalized Medicine, Volume 19, 1-8. https://doi.org/10.2147/pgpm.s568037
Vancouver
Khan N, Jonnalagadda M, Kumar R, Das A. NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy. Pharmacogenomics and Personalized Medicine. 2026;Volume 19:1-8. doi:10.2147/pgpm.s568037
BibTeX
@article{Khan2026,
author = {Khan, Nikhat and Jonnalagadda, Manjari and Kumar, Ravindra and Das, Aparup},
title = {NAT2 Acetylation Phenotypes in India: A Narrative Review of Personalized TB Therapy},
journal = {Pharmacogenomics and Personalized Medicine},
year = {2026},
volume = {Volume 19},
pages = {1--8},
doi = {10.2147/pgpm.s568037}
}
EUVIMED